Mexico Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence on Mexico’s Pharmaceuticals and Healthcare Industry

2008-07-25 05:20:00

Mexico Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence on Mexico’s Pharmaceuticals and Healthcare Industry

DUBLIN, Ireland–(EMWPresswire)–Research and Markets (http://www.researchandmarkets.com/research/c37020/mexico_pharmaceuti)

has announced the addition of the “Mexico Pharmaceuticals and Healthcare

Report Q3 2008” report to their offering.

Mexico Pharmaceuticals and Healthcare Report provides independent

forecasts and competitive intelligence on Mexico’s pharmaceuticals and

healthcare industry.

Mexicos pharmaceutical market is expected to

continue its rapid growth over the forecast period to reach a value of

US$28.3bn by 2012, up from an estimated US$14.9bn in 2007. A worsening

chronic disease burden and increased health insurance uptake should

drive volume growth in the pharmaceutical market, while a relatively

free pricing environment when compared with other Latin American markets

should further aid value growth.

The pharmaceutical market is expected to grow 12.9% in local currency in

2008, driven as in the past few years, by moves to more expensive

bioequivalent generics and rising personal wealth. However, the oneoff

gains from stronger bioequivalence regulation driving up the value of

the generics market are expected to wear off over the forecast period,

resulting in market growth to fall back into line with GDP by the end of

the forecast period. The government remains committed to ensuring

similares, or copies without proven bioequivalence, are eradicated from

the market by early 2010.

Key Topics Covered:

Executive Summary

Mexico Pharmaceuticals And Healthcare Industry SWOT

Mexico Political SWOT

Mexico Economic SWOT

Mexico Business Environment SWOT

Pharmaceutical Business Environment Ratings

Limits Of Potential Returns

Risks To Realisation Of Returns

Mexico Market Summary

Regulatory Regime

Intellectual Property Environment

Pricing And Reimbursement Issues

Other Regulatory Developments

Industry Developments

Healthcare Sector

Pharmaceutical Sector

Generics Sector

Multinational Activity

Research And Development Sector

Industry Forecast Scenario

Overall Market Forecast

Key Growth Factors Industry

Key Growth Factors Macroeconomic

Prescription Market Forecast

OTC Market Forecast

Generics Market Forecast

Medical Device Market Forecast

Top Ten Causes Of Death In Mexico, 2002

Pharmaceutical Export/Import Forecasts

Key Risks To BMIs Forecast Scenario

Company Monitor

Leading Foreign Companies

Pfizer

GlaxoSmithKline (GSK)

Sanofi-Aventis

Eli Lilly

Bristol-Myers Squibb (BMS)

Novartis Farmacéutica

Bayer

Boehringer Ingelheim Promeco

Merck KGaA

Roche

Indigenous Manufacturer Profile

Liomont

Strides Latina (Solara)

BMI Forecast Modelling

How We Generate Our Pharmaceutical Industry Forecasts

Pharmaceutical Business Environment Ratings Methodology

Ratings Overview

Weighting

Sources

For more information visit http://www.researchandmarkets.com/research/c37020/mexico_pharmaceuti

Research and Markets
Laura Wood, Senior Manager
Fax from USA:

646-607-1907
Fax from rest of the world: +353-1-481-1716
press@researchandmarkets.com

free cash grants, free grant money, free money, cash grants, scholarships, business grants, foundation grants, government grants, debt grants, consolidation, college tuition, financial aid, medical grants, personal grants, medical bills, unsecured loans, no interest loans, financing, loans, capital, non profit organizations

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions